«Ariel Fernández». Fellows. John Simon Guggenheim Memorial Foundation. Archivado desde el original el 4 de enero de 2013. Consultado el 27 de septiembre de 2012.
Philip Ball para Nature News. The Achilles' heel of biological complexity. 18 Mayo 2011 [6]
Crunkhorn S. Anticancer drugs: Redesigning kinase inhibitors. February 2008. Nature Revs Drug Discovery 7:120-121 doi 10.1038/nrd2524 [7]
nih.gov
ncbi.nlm.nih.gov
Fernández A, Scott R. Dehydron: a structurally encoded signal for protein interaction. Biophys J. 2003 Sep;85(3):1914-28. PMID 12944304[2]
Fernández A, Scott R. Adherence of packing defects in soluble proteins. Phys Rev Lett. 2003 91(1):018102. PMID 12906578[3]
Demetri G. D. Structural reengineering of imatinib to decrease cardiac risk in cancer therapy.2007 Dec 3; J Clin Invest. 117(12):3650–3653. doi 10.1172/JCI34252 [9]
Fernandez A., Berry R. S. Molecular dimension explored in evolution to promote proteomic complexity. Proc Natl Acad Sci USA 2004 September 3;101(37):13460–13465, doi 10.1073/pnas.0405585101 [5]
Boyd J. for Rice University News and Media. Drug design: New book introduces fresh approach. 28 April 2010 [8]Archivado el 1 de septiembre de 2016 en Wayback Machine.
rsc.org
Ball, P. A Sticky End? Chemistry World, The Royal Society of Chemistry, August 2011 www.chemistryworld.org, [4]
Boyd J. for Rice University News and Media. Drug design: New book introduces fresh approach. 28 April 2010 [8]Archivado el 1 de septiembre de 2016 en Wayback Machine.
«Ariel Fernández». Fellows. John Simon Guggenheim Memorial Foundation. Archivado desde el original el 4 de enero de 2013. Consultado el 27 de septiembre de 2012.